Mxt Biotech Co.
Latest round
- Series A
Last raised
- May 2022
Total raised
- $4.3M
Investors
- 6
About Mxt Biotech Co.
, Ltd.a. MxT Biotech develops microfluidic-based intracellular substance delivery and gene correction services. The company also provides automated process equipment for the mass production of cell therapeutics., Ltd. The company’s technology includes Hydroporator, a non-virus-based intracellular material delivery platform used for the delivery of external cargos like proteins, mRNA, plasmid DNA, nanoparticles, and CRISPR-Cas9 RNPs into the primary cells for cancer immunotherapy, cellular engineering, and genome editing.
Who invested in Mxt Biotech Co.
6 investors across 2 rounds
See all investors in Mxt Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mxt Biotech Co.
Who invested in Mxt Biotech Co.?
Mxt Biotech Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mxt Biotech Co. raised?
Mxt Biotech Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mxt Biotech Co. last raise money?
Mxt Biotech Co.'s most recent round on record is a Series A, in May 2022.
What does Mxt Biotech Co. do?
Mxt Biotech Co. is a biotechnology company.
Where is Mxt Biotech Co. headquartered?
Mxt Biotech Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Mxt Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Mxt Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mxt Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.